DSG News Articles - 2009
OCTOBER, 2009 A clear and present danger has emerged for the pharmaceutical and medical device industry that threatens its very core. After a wave of criticism about the way federal drug regulators are performing their duty, a Supreme Court majority handed down a decisive endorsement of lawsuits in state courts to address deficiencies at the national level.
100% EDC, A Necessity. From “Is 100% EDC Realistic?” presented by Suzanne Lamerand of DSG, Inc. at the 2009 SCDM Annual Conference, 2009.
The pharmaceutical and device industry faces a hostile litigious and regulatory environment. This current climate can stifle research and, as a result, impede progress that could improve the healthcare of all Americans. The concern is over a new level of scrutiny aimed at pharmaceutical and medical device companies. The good news is that the industry can employ existing technologies to head off potential problems and dramatically reduce risk. That technology is EDC.
DSG in the Spotlight at 2009 SCDM Annual Conference
(01 Oct 2009) -DSG's EDC technology presence at 2009 SCDM conference highly anticipated - MALVERN, Pa.--(Business Wire)-- DSG, Inc., the leader in EDC and clinical software technology, is already the center of attention leading up to the 2009 SCDM Annual Conference. The excitement is centered around DSG`s continuing role as a pioneer in the EDC(electronic data capture) field, with over 500 attendees eager to see the latest developments and the future of EDC from DSG.
Cipher Uses DSG`s EDC in Effort to Give Hope to Severe Acne Sufferers
Cipher Pharmaceuticals conducts Phase 3 trial study for new severe acne treatment- MALVERN, Pa.-- DSG Inc., an industry leader in clinical trial data collection and management, today announced that Cipher Pharmaceuticals (TSX:DND) is using electronic data capture (EDC) software and data management services from DSG. Cipher is using DSG`s eCaseLink for its Phase 3 dermatology study on its new compound for the treatment of severe acne. Cipher`s new treatment offers new hope for patients with severe inflammatory or recalcitrant nodular acne who are unresponsive to conventional therapy.
DSG’s Successes with Human Genome Sciences By Lisa Henderson | Published: September 2, 2009
In covering clinical trials, we are seeing more focus on the activities in specific therapeutic areas. Not that they didn’t exist before, but the frequency with which companies are identifying the specific conditions for which they have experience are on an uptick. These experiences can parlay into other contracts in similar conditions, or add to the company’s cadre of experience, as well as the overall impression, the company already exhibits.
Human Genome Sciences Achieves Lupus Drug Goals With DSG`s EDC
(17 Aug 2009) Human Genome Sciences announced that BENLYSTA met the primary endpoint in BLISS-52, the first of two pivotal Phase 3 trials in patients with serologically active systemic lupus erythematosus (SLE). These results show that BENLYSTA has the potential to become the first new approved drug in decades giving hope to people living with systemic lupus. DSG supports HGS on four global Phase 3 studies concurrently, providing data capture and supporting data management through its function rich eCaseLink EDC software. The study included nearly 400 electronic case report forms per subject, which were highly complex in design and had nearly 1,200 edits per screen. DSG provided critical data reporting tools based on study requirements, allowing HGS data management personnel to continually monitor and efficiently insure data quality.
DSG Announces Record Growth for First Half of 2009
(22 June 2009) DSG Inc., the industry leader in electronic data capture (EDC) for clinical trial data collection and management, today announced, from the 45th Annual Meeting of the Drug Information Association, its continued record growth and profitability for the first half of 2009.
DSG, Inc. wins SCDM Data Driven Innovation Award for second year in a row
January. 13, 2009 DSG’s collaborative work with Human Genome Sciences wins key industry award...
In its second year, the Data Driven Innovation Award recognizes and honors excellence in the advancement of clinical data management and celebrates innovation in vendor/sponsor relationships. Three judges selected from the SCDM Certified Clinical Data Managers agreed to honor the partnership between HGS and DSG for creating an interactive and centralized Clinical Data Quality Control (CDQC) checklist that combines both system data and user entered data to assess the status of "cleanliness" for a given project.
DSG News Articles - 2008
May 13, 2008 DSG, Inc., a leading EDC and clinical software technology provider, today announced that OVATION Pharmaceuticals, Inc. (OVATION) is using DSG’s award-winning eCaseLink EDC software to conduct several Phase I clinical trials. DSG is one of OVATION’s preferred providers for EDC software for these studies.
To date, OVATION has used eCaseLink for five Phase I studies, and has seven Phase I studies underway or planned for 2008 and six Phase I studies planned for 2009.
DSG News Articles - 2007
Philadelphia Business Journal Profiles DSG
November 1, 2007 DSG places number 40 among the fastest-growing private companies in the region...
The survey was conducted jointly by the Philadelphia Business Journal and the Wharton Small Business Development Center. Rankings are based on revenue growth over the past three years. DSG supports clinical trial data collection globally through its eCaseLink EDC software,electronic patient diaries, and Clinical Trial Management Systems software.
CenterWatch Weekly Highlights DSG's EDC, Randomization, and Supply Integration
October 08, 2007 - DSG has replaced the need to use an interactive voice response system (IVRS) for complex randomization to obtain drug kit numbers, thus cutting out a third technology vendor. By using eSourcing on a tablet PC and DSG’s eCaseLink EDC system, site investigators were able to record patient information in real time and receive randomized and blinded kit numbers for drugs already shipped from the sponsor.
CenterWatch Weekly Highlights DSG's new multi-language eCaseLink clinical trial software
April 16, 2007 - Thomson CenterWatch, the industry publication covering financial and business news for clinical trials, acknowledges the release of DSG's New eCaseLink EDC clinical trial software with multi-language capabilities.
DSG News Articles - 2006
CenterWatch Weekly Highlights Dismissal of Datasci Lawsuit
December 20, 2006 - Thomson CenterWatch, the industry publication covering financial and business news for clinical trials, acknowledges the dismissal of the lawsuit between Datasci and DSG. Pennsylvania-based Document Solutions Group (DSG) has settled a longstanding, patent infringement suit filed by St. Paul,Minn.-based technology company Datasci. Datasci filed similar lawsuits against eClinical companies Phase Forward, Datatrak, eTrials and DataLabs.
DSG Launches Data Management Division
December 20, 2006 - By Ann Neuer
DSG, Inc. expands their service clinical trial study offerings.
With adoption of electronic data capture (EDC) trending upward at a healthy clip, provider DSG Inc. is riding the wave by offering clinical data management services to its EDC customers through a newly created Data Management Division. Launched in mid-2006, the division provides an array of services such as design and review of electronic case report forms, data encoding, and ongoing review of data and logic checks.
CenterWatch Weekly Highlights DSG's New Data Management Division
November 26, 2006 - Thomson CenterWatch, the industry publication covering financial and business news for clinical trials acknowledges DSG's new Data Management Division.
Datasci Suits Threaten Industry, Vendors.
September 11, 2006 - The U.S. Patent Office is under scrutiny in a series of lawsuits that are baffling the world of clinical trial software technology.
February 2006 - Tony Varano, President and CEO, speaks about the different software technology options available.
In the past several years, eClinical technologies have become a more widely-used asset in clinical trials due to their effectiveness compared to paper processes. With the elimination of paper CRF books and, in some cases, clinical data management systems, technologies such as electronic data capture and electronic patient-reported outcomes have proven to be more cost-effective, timely, and easier to use.
DSG News Articles - 2005
DSG Takes on MS Registry
December 19, 2005 Tony Varano, President and CEO of DSG, is interviewed by Mark Uehling, Senior Editor of BioIT World, to discuss the Accelerated Cure Project, Electronic Data Capture, CaseView, and eSource.
DSG Move Attracts Attention
0ctober 12, 2005Fantastic growth has required DSG, the industry’s largest privately-held EDC (electronic data capture) solutions provider, to acquire a state of the art facility to accommodate its rapid expansion. DSG has now completed the move to their new global corporate headquarters in the Great Valley Corporate Center in Malvern, Pennsylvania.
CenterWatch Weekly Highlights DSG's New Client Wins
September 20, 2005Thomson CenterWatch, the industry publication covering financial and business news for clinical trials acknowledges DSG's pivotal wins using CaseView for clinical studies.